Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.

 
A key drug for the treatment of leprosy, clofazimine has recently been associated with highly effective and significantly shortened regimens for the treatment of multidrug-resistant tuberculosis (TB). Consequently, researchers hypothesized that clofazimine may also shorten the duration of treatment for drug-susceptible TB. Clofazimine is a promising anti-TB drug with the potential to shorten the duration of TB chemotherapy by at least half (3 month vs. 6 month standard treatment) in the mouse model of TB.
Source : www.tb-net.org      2015/4/14 08:32

خانه چاپ ارسال به دوستان نسخه متنی کوچک کردن متن بزرگ کردن متن دانلود خروجی پی دی اف خروجی میکروسافت ورد
0/10 (تعداد آرا 0 نفر )
Copyright © 2011 AASM. All Rights Reserved.